Back

prof. dr. A.C.G. (Toine) Egberts

prof. dr. A.C.G. (Toine) Egberts

Full Professor
prof. dr. A.C.G. (Toine) Egberts
  • Clinical Pharmacy

Biography

Biography

Toine Egberts (1965) obtained his PharmD in 1990 at the University of Groningen, the Netherlands. Thereafter he was trained as a clinical pharmacist during four years in the hospitals of Tilburg and Delft. In 1994, he started his PhD project at the department of Pharmacoepidemiology & Clinical Pharmacology of Utrecht University in collaboration with the Netherlands Pharmacovigilance Foundation 'Lareb'. This resulted in 1997 in a thesis entitled 'Pharmacoepidemiologic approaches to the evaluation of antidepressant drugs'. During his PhD-project he obtained the Master of Science degree in clinical epidemiology at the Netherlands Institute of Health Sciences.

He was appointed in 2001 as professor of clinical pharmacoepidemiology at the department of Pharmacoepidemiology & Clinical Pharmacology. Since 2006 he is also a professor of clinical pharmacy at the medical faculty of Utrecht University. In these positions he tries to bridge the drug environment and the patient environment.

From 2006 - 2017 he was the chief pharmacist of the department of clinical pharmacy of the University Medical Center Utrecht.

Since november 2018 he is director of doctor education of the Graduate School of Life Sciences of the Utrecht University. The coaching of PhD students gives him energy as it nicely balances performing research into medical/pharmaceutical puzzles with the personal development of young academic professionals. He had the opportunity to guide over 65 PhD students towards the 'hora est'. He has always been deeply involved in education, especially the training of hospital pharmacists, for which he received in 2016 the 'Senior Jan Glerum Award'.

He is (co)author of approximately 500 international peer reviewed scientific publications and a reviewer for several scientific journals and international research funding organisations.

He is a member of the editorial board of the journal Drug Safety. He is member of several committees such as the CCMO, the Netherlands Expertcenter for Pharmacotherapy for older people (EPHOR), the scientific advisory board of the Mental Health Center of the University of Wurzburg.

His research activities focus on a) the clinical pharmacology / clinical pharmacoepidemiology of drugs used in the treatment of psychiatric and neurologic disorders, and b) on innovations in clinical pharmacy systems.

He is married to Karin, has two daughters (Bibi and Louisa) and one son (Kilian) and in his spare time he likes to (trail)run, bootcamp, climb mountains and to play / listen to music.

Side Activities

All mentioned activities are current:

  • professor of clinical pharmacy, department of pharmaceutical sciences Utrecht University
  • director of doctoral education Graduate School of Life Sciences Utrecht University
  • member Centrale Commissie Mensgebonden Onderzoek (CCMO)
  • advisor clinical pharmacology group Jeroen Bossch Ziekenhuizen
  • member advisory board Dutch Association Hospital Pharmacists NVZA
  • member advisory board Utrecht Centre for Affordable Biotherapeutics (UCAB)
  • member supervisory board SIR Institure for Pharmacy Practice and Policy
  • reviewer of project proposals for funding organizsations such as ZonMw
  • member of the editorial board of the journal Drug Safety
  • reviewer for several other biomedical journals
  • board member of the Netherlands Expertcenter for Pharmacotherapy for older people (EPHOR)
  • member scientific advisory board Zentrum fur Psychische Gesundheit, Uniklinikum Wurzburg, Germany

Fellowship and Awards

Huizinga Penning (2004)

Senior Jan Glerum prijs (2016)

Research Output (545)

Geneesmiddelverspilling in het ziekenhuis

Jongsma Minke E, Bogaards Marja J, Grassi Jiro B, van der Valk Rixt, Egberts A Toine C G, Ossebaard Hans C 14 Nov 2022, In: Nederlands Tijdschrift voor Geneeskunde. 166

Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

Sallevelt Bastiaan T G M, Egberts Toine C G, Huibers Corlina J A, Ietswaart Jimmy, Drenth-van Maanen A Clara, Jennings Emma, O'Mahony Cian, Jungo Katharina Tabea, Feller Martin, Rodondi Nicolas, Sibille François-Xavier, Spinewine Anne, van Puijenbroek Eugène P, Wilting Ingeborg, Knol Wilma 1 Nov 2022, In: Drug Safety. 45 , p. 1501-1516 16 p.

Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products:A 20-year follow-up study of originators and biosimilars

Alsamil Ali M, Giezen Thijs J, Egberts Toine C, Doevendans Erik, Leufkens Hubert G, Gardarsdottir Helga 1 Aug 2022, In: European Journal of Pharmaceutical Sciences. 175 , p. 1-8

Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients

Wasylewicz Arthur T M, van de Burgt Britt W M, Manten Thomas, Kerskes Marieke, Compagner Wilma N, Korsten Erik H M, Egberts Toine C G, Grouls Rene J E Aug 2022, In: Clinical Pharmacology and Therapeutics. 112 , p. 382-390 9 p.

Systemic glucocorticoid use during ICU admission and symptoms of posttraumatic stress disorder in intensive care unit survivors

van Gelder Thomas G, Lalmohamed Arief, van Diem-Zaal Irene J, Egberts Toine C G, Slooter Arjen J C 13 May 2022, In: Intensive Care Medicine. 48 , p. 762-764 3 p.

Impulse control disorders associated with dopaminergic drugs:A disproportionality analysis using vigibase

De Wit Laura E, Wilting Ingeborg, Souverein Patrick C, van der Pol Peggy, Egberts Toine C G May 2022, In: European Neuropsychopharmacology. 58 , p. 30-38 9 p.

Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A:A method validation study

Donners Anouk A.M.T., Gerencsér László, van der Elst Kim C.M., Egberts Toine C.G., de Maat Moniek P.M., Huisman Albert, Urbanus Rolf T., El Amrani Mohsin May 2022, In: Research and practice in thrombosis and haemostasis. 6 , p. 1-9

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Bognàr Tim, Bartelink Imke H, Egberts Toine C G, Rademaker Carin M A, Versluys A Birgitta, Slatter Mary A, Kletzel Morris, Nath Christa E, Cuvelier Geoffrey D E, Savic Rada M, Dvorak Christopher, Long-Boyle Janel R, Cowan Morton J, Bittencourt Henrique, Bredius Robbert G M, Güngör Tayfun, Shaw Peter J, Ansari Marc, Hassan Moustapha, Krajinovic Maja, Hempel Georg, Marktel Sarah, Chiesa Robert, Théoret Yves, Lund Troy, Orchard Paul J, Wynn Robert F, Boelens Jaap Jan, Lalmohamed Arief Apr 2022, In: Transplantation and Cellular Therapy. 28 , p. 196-202 7 p.

The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients

de Jong Corine, Chargi Najiba, Herder Gerarda J.M., van Haarlem Simone W.A., van der Meer Femke, van Lindert Anne S.R., ten Heuvel Alexandra, Brouwer Jan, de Jong Pim A., Devriese Lot A., Huitema Alwin D.R., Egberts Toine C.G., de Bree Remco, Deneer Vera H.M. 2022, In: Journal of Cachexia, Sarcopenia and Muscle. 13 , p. 1554-1564 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet